Sanofi (SNY) Total Debt (2009 - 2025)

Sanofi (SNY) has 17 years of Total Debt data on file, last reported at $21.6 billion in Q4 2025.

• Quarterly Total Debt rose 26.57% year-over-year to $21.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.6 billion (up 26.57% YoY) and the FY2025 annual result came in at $21.6 billion, up 26.57% from the prior year.
• Total Debt declined to $21.6 billion in Q4 2025 per SNY's latest filing, from $23.2 billion in the prior quarter.
• The five-year high for Total Debt was $24.3 billion in Q2 2021, with the low at $17.1 billion in Q4 2024.
• Average Total Debt over 5 years is $21.1 billion, with a median of $21.1 billion recorded in 2023.
• Year-over-year, Total Debt slipped 16.47% in 2022 and climbed 26.57% in 2025.
• Sanofi's Total Debt stood at $23.2 billion in 2021, then declined by 16.42% to $19.4 billion in 2022, then slipped by 9.17% to $17.6 billion in 2023, then decreased by 3.06% to $17.1 billion in 2024, then advanced by 26.57% to $21.6 billion in 2025.
• Business Quant data shows SNY's Total Debt at $21.6 billion in Q4 2025, $23.2 billion in Q2 2025, and $17.1 billion in Q4 2024.